52 Week Range
As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Shin-Etsu Chemical May Spend 30 Bln Yen To Raise Capacity For Semiconductor Plant Material - Nikkei
Shin-Etsu Chemical Co Ltd Says To Buy Back Up To 3.3 Percent Of Own Shares Worth 100 Billion Yen
Shin-Etsu Chemical Co Plans To Boost Silicone Output By 50 Pct From Current Level By End 2020-Nikkei
Shin-Etsu Chemical Co., Ltd. is a Japan-based company primarily engaged in chemical business. The Company operates in six business segments. The Poly Vinyl Chloride and Chemicals segment manufactures and sells vinyl chloride, caustic soda products, chloromethane and methanol. The Silicone segment manufactures and sells Silicone products. The Functional Chemicals segment manufactures and sells cellulose derivatives, metal silicon, poval and synthetic sex pheromone. The Semiconductor Silicon segment manufactures and sells semiconductor silicon products. The Electronic and Functional Materials segment manufactures and sells rare earth magnet, packaging materials for Light Emitting Diode (LED), photoresists, mask blanks, synthetic quartz products, liquid fluoroelastomer and pellicle. The Process, Commercial and Technology Service segment provides resin processed products, exports technology and plant and others.
Chemicals - Plastics & Rubber
Asahi Seimei Otemachi Bldg.
Chairman of the Board, Chairman of Subsidiary, Representative Director
President, President of Subsidiaries, Representative Director
Vice Chairman of the Board, President of Subsidiary, Representative Director
Senior Managing Director, Director of Operation in Semiconductor Business Unit
Senior Managing Director, Chief Director of Silicone Business
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Japan's benchmark Nikkei share average inched up to close at a fresh three-decade high on Tuesday, as drug makers led the charge on a report that Chugai Pharmaceutical's drug was effective in treating COVID-19 patients.
Japan's benchmark Nikkei share average recovered from early falls on Tuesday to hit a fresh three-decade high, with drug makers leading the charge following a report of another effective COVID-19 treatment.
Japan's Nikkei share average ended lower on the last trading day of the year, retreating from a more than three-decade high hit in the previous session as investors booked profits, but it logged gains for a second straight year.
Japan's Nikkei share average retreated from a more than three-decade high in early trade on Wednesday as investors locked in some profits after a rally, but the market stayed on course for a second year of gains.
Japanese shares were little changed in holiday-thinned trade on Friday but some investors bought pro-cyclical stocks that are expected to perform well next year as the global economy recovers from the coronavirus pandemic.
Siltronic said on Wednesday its management agreed to the takeover of the German silicon wafer maker by Taiwan's GlobalWafers for 3.75 billion euros ($4.53 billion).
Japan shares closed lower on Monday, with the Nikkei pulling back from a more than 29-1/2-year high, as five straight weeks of gains raised some concerns of an overheating market and spurred investors to book profits.
Japan's benchmark Nikkei share average pulled back from a more than 29-1/2-year high on Monday, as investors chose to pocket profits amid some concerns of overheating after five consecutive weeks of gains.
Japan's benchmark Nikkei closed near a 29-1/2-year high on Tuesday, tracking gains in U.S. stock futures over growing optimism that major drugmakers will roll out coronavirus vaccines before year-end.
Japanese shares rose toward a 29-year high on Tuesday, tracking gains in U.S. stock futures on the back of growing optimism that major drugmakers will roll out coronavirus vaccines some time before the end of the year.
Shares in Siltronic jumped on Monday after the German silicon wafer maker said on Sunday it was in advanced talks to be bought by Taiwan's GlobalWafers in a 3.75-billion-euro ($4.5 billion) deal.
German chipmaker Siltronic said on Sunday it is in advanced takeover talks with Taiwan's GlobalWafers in a 3.75-billion-euro deal ($4.5 billion) to create a leading player in the wafer industry.
Japan shares closed firmer on Wednesday, taking positive cues from Wall Street as the Dow Jones benchmark scaled a record high overnight, with investor sentiment lifted by vaccine optimism and fading U.S. election uncertainty.
Japan shares rose on Wednesday, taking positive cues from Wall Street as Dow Jones benchmark scaled a record high overnight, with investor sentiment lifted by vaccine optimism and fading U.S. election uncertainty.
Japanese shares hit multi-year highs on Tuesday as progress in developing an inexpensive coronavirus vaccine boosted hopes of a swift economic recovery, with sentiment aided by a formal transition approval for U.S. President-elect Joe Biden.
Japanese shares hit a 29-year high on Tuesday as progress in developing an inexpensive coronavirus vaccine boosted hopes of a swift recovery, while a formal transition approval for U.S. President-elect Joe Biden also lifted sentiment.
Japanese shares fell to a one-month low on Thursday weighed by concerns about fresh coronavirus lockdowns in Europe, although companies issuing bullish forecasts during earnings season limited losses.
Japanese shares fell to a one-month low on Thursday as the return of coronavirus lockdowns in France and Germany put a damper on investor sentiment only days before the U.S. presidential election.
Japanese shares fell on Thursday as a rise in the yen threatened earnings of export-focused stocks, while uncertainty ahead of the U.S. presidential election weighed on sentiment.
Japan's Nikkei share average hit a six-month high on Thursday and reached its highest level in three decades in dollar terms, as hopes of more global and domestic economic stimulus boosted sentiment.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.